The Imperial College Innovation Fund (ICIF), an early-stage investment fund launched at Imperial in early 2020 and managed by Parkwalk Advisors to invest in early-stage, high-growth, knowledge-intensive companies, has completed its first investment of £205,000 into Charco Neurotech. 

The team of designers, doctors, engineers and scientists at Charco Neurotech are developing a non-invasive vibrating device called CUE1 to help manage Parkinson’s symptoms. The investment from ICIF is part of a £500,000 seed round from investors, including Amadeus Capital Partners, Crista Galli, RCA and Oxbridge Angels. The investment will be used to launch CUE 1 in the UK/EU market in early 2021.